NCT06101394View on ClinicalTrials.gov

Development of a Fluorescent Visualization System for Non-visible Lung Cancer Nodules

PHASE2RecruitingINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

January 31, 2024

Primary Completion Date

July 31, 2025

Study Completion Date

December 31, 2025

Conditions
Lung CancerVideo-assisted Thoracic SurgeryEGFRCetuximab
Interventions
DRUG

Cetuximab-IRDye800

Infusion of the study drug will be performed 2-5 days before the surgery: the patients will receive 100 mg of cetuximab intravenously over 30 minutes and a dose 50 mg of cetuximab-IRDye800 over 30 minutes to 1 hour.

Trial Locations (2)

10126

NOT_YET_RECRUITING

Azienda Ospedaliera Universitaria Città della Salute e della Scienza di Torino, Torino

RECRUITING

S.C. Chirurgia Toracica U, Città della Salute e della Scienza di Torino, Torino

All Listed Sponsors
collaborator

A.O.U. Città della Salute e della Scienza

OTHER

lead

University of Turin, Italy

OTHER